Tag: Immutep Limited


Immutep Limited (NASDAQ: IMMP) to Assess Efti in Tripartite Grouping Treatment Phase I Learning

Immutep Limited (NASDAQ: IMMP) proclaims it has initialed a contract to begin a new Phase I pilot, called INSIGHT-003. The pilot will assess the mixture of principal creation applicant “efti” or “IMP321” combined with an obtainable accepted customary of care treatment containing a chemotherapy go-between and an anti-PD-1 treatment. INSIGHT-003 […]